Sato N, Marubashi S. What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection? Surg Today. 2022;52(6):871–80.

PubMed  Google Scholar 

Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, et al. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol. 2023;29(8):1243–60.

CAS  PubMed  PubMed Central  Google Scholar 

Papaconstantinou D, Tsilimigras D, Pawlik MT. Recurrent Hepatocellular Carcinoma : Patterns, Detection. Staging and Treatment J Hepatocell Carcinoma. 2022;9:947–57.

PubMed  Google Scholar 

Hirokawa F, Hayashi M, Asakuma M, Shimizu T, Inoue Y, Uchiyama K. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma. Surg Oncol. 2016;25:24–9.

PubMed  Google Scholar 

Yilma M, Saxena V, Metha N. Models to Predict Development or Recurrence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis. Curr Gastroenterol Rep. 2022;24:1–9.

PubMed  PubMed Central  Google Scholar 

Xu X, Xing H, Han J, Li Z, Lau WY, Zhou YH, et al. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma Multicenter Study From China. JAMA Surg. 2019;154(3):209–17.

PubMed  Google Scholar 

Cho H, Kim B, Kim JH, Huh J, Kim JK, Lee JH, et al. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Eur Radiol. 2020;30(8):4182–92.

PubMed  Google Scholar 

Zhang L, Chen J, Jiang H, Rong D, Guo N, Yang H, et al. MR elastography as a biomarker for prediction of early and late recurrence in HIV-related hepatocellular carcinoma patients before hepatectomy. Eur J Radiol. 2022;152: 110340.

PubMed  PubMed Central  Google Scholar 

Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25(40):6041–52.

PubMed  PubMed Central  Google Scholar 

Yoo S, Wang W, Wang Q, Fiel MI, Lee E, Hiotis SP, et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med. 2017;15(1):214.

PubMed  PubMed Central  Google Scholar 

Sato N, Kenjo A, Nishimagi A, Kimura T, Okada R, Ishigame T, et al. Accuracy comparison of MR elastography and biological makers in detecting liver fibrosis and predicting postoperative ascites. HPB (Oxford). 2021;23(9):1383–91.

PubMed  Google Scholar 

Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, et al. Direct Comparison of US and MR elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022;20(4):908–17.

PubMed  Google Scholar 

Sato N, Kenjo A, Kimura T, Okada R, Ishigame T, Kofunato Y, et al. Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography. Br J Surg. 2018;105(9):1192–9.

CAS  PubMed  Google Scholar 

Moazzam Z, Alamimo L, Endo Y, Lima HA, Woldesenbet S, Rueda BO, et al. A prognostic model to predict survival after recurrence among patients with recurrent hepatocellular carcinoma. Ann Surg. 2024;279(3):471–8.

PubMed  Google Scholar 

Abe H, Shibutani K, Yamazaki S, Kanda T, Moriyama M, Okada M, et al. Tumor stiffness measurement using magnetic resonance elastography can predict recurrence and survival after curative resection of hepatocellular carcinoma. Surgery. 2021;170(1):167–72.

PubMed  Google Scholar 

Lee JH, Hwang JA, Gu K, Shin J, Han S, Kim YK. Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma. Magn Reson Imaging. 2024;109:127–33.

PubMed  Google Scholar 

Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–8.

PubMed  Google Scholar 

Hagstrom H, Talback M, Andreasson A, et al. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J Hepatology. 2020;73(5):1023–9.

Google Scholar 

Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, et al. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. World J Gastroenterol. 2015;21:1207–15.

PubMed  PubMed Central  Google Scholar 

Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200–7.

PubMed  Google Scholar 

Lee AH, Lee YS, Kim KB, Jung YK, Kim SU, Park JY, et al. Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma. Gut Liver. 2021;15(3):420–9.

PubMed  Google Scholar 

Yun SO, Kim JM, Rhu J, et al. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations. Ann Surg Treat Res. 2023;104(4):195–204.

CAS  PubMed  PubMed Central  Google Scholar 

Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, Beek LC, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 2006;19(2):173–9.

PubMed  Google Scholar 

Rouviere O, Yin M, Dresner AM, Rossman PJ, Burgart LJ, Fidler JL, et al. MR elastography of the liver: preliminary results. Radiology. 2006;240(2):440–8.

PubMed  Google Scholar 

Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo Imaging Grading of Liver Fibrosis. J Clin Transl Hepatol. 2018;6(2):198–207.

PubMed  PubMed Central  Google Scholar 

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626–37.

PubMed  Google Scholar 

Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, et al. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019;17:630–7.

PubMed  Google Scholar 

Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66(5):1486–501.

CAS  PubMed  Google Scholar 

Huttman M, Parigi TL, Zoncapè M, et al. Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C. Cochrane Database Syst Rev. 2024;8(8):CD011929.

PubMed  Google Scholar 

Sakon M, Umeshita K, Nagano H, Eguchi H, Kishimoto S, Miyamoto A, et al. Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease free survival curves. Arch Surg. 2000;135(12):1456–9.

CAS  PubMed  Google Scholar 

Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, et al. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol. 2022;14(9):1604–21.

PubMed  PubMed Central  Google Scholar 

Crook C, Li D. Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma. Curr Oncol Rep. 2023;25(10):1191–201.

PubMed  PubMed Central  Google Scholar